IL1B and COVID-19: Excessive inflammation has emerged as an important aspect of COVID-19 pathophysiology, and the anti-inflammatory steroid dexamethasone has been shown to improve outcomes among those with severe disease.18 The interaction between the NH Black population and IL-1B raises the possibility that differences in immunity may contribute to worse outcomes in some patients.